Combination of Two Drugs better than currently used one in Case of Untreated Melanoma

An immunotherapy combination for untreated melanoma was found to be more successful in reducing the risk of death and progression of the disease than a drug currently used as a standard of care.

Researchers shared data that patients treated with nivolumab (Opdivo) and ipilimumab (Yervoy) lived progression-free survival (PFS) for 11.5 months in comparison with ipilimumab alone (2.9 months) and 6.9 months with nivolumab monotherapy.

Among patients who tested positive for programmed death receptor ligand 1 (PD-L1), median PFS counted with the combination and nivolumab alone was found to have increased to 14 months. Researchers said that the time period was four times more than the PFS patients who just received ipilimumab.

Four Former Store Detectives file Class-Action Lawsuit against CVS

Four former employees of CVS in New York have claimed that their bosses asked them to target black and Hispanic shoppers. On Wednesday, they filed a class-action lawsuit against the drug-store chain.

They have also alleged that they were sacked out of the job after they complained about racial discrimination, against customers as well as them. The plaintiffs who are either black or Hispanic said that their two supervisors in CVS’s loss-prevention department used to ask them to racially profile nonwhite shoppers.

Advisory Committee to Discuss Sprout Pharmaceutical's Drug ‘Flibanserin’

A drug nicknamed ‘female Viagra’ will be discussed for the third time at a meeting of an advisory committee to US regulators on Thursday.

If the US Food and Drug Administration (FDA) approves the drug, it will be the first drug in the market to boost female libido. So far two attempts to bring the drug to market have failed in 2010 and 2013. As per experts, the drug has several loopholes that need to be looked after.

Flibanserin, aimed at pre-menopausal women, can have significant side-effects, including nausea, dizziness and sleepiness, said experts.

On Thursday, the committee will hear the evidences from clinical studies of the drug and from experts, both in favor and against it.

Breast Screening Helps Save Lives, Say Experts

A latest international panel of experts after studying the most recent evidence on mammograms to screen for breast cancer recommended that breast screening proves beneficial for women in their 50s and 60s.

The study has been made public after long debates about the pros and cons of the procedure. The study led by the World Health Organization's cancer agency included 29 independent experts from 16 countries who looked at 40 different studies.

The study’s findings, published in the New England Journal of Medicine, support current National Health Service (NHS) advice, which recommends women aged 50-69 are screened every three years.

It showed that the population of women going for breast screening in England has went down slightly over the past few years.

MERS raises concerns in South Korea

On Thursday, warning regarding an outbreak of Middle East Respiratory Syndrome (MERS) in South Korea was issued. It has been demanded that strict border checks should be conducted. Five new cases of the disease have been reported.

South Korean President Park Geun-hye said efforts are required to stop the outbreak that started two weeks ago. He added that the disease entered the country when a South Korean man came back from a business trip to the Middle East. The disease caused death of two people. There have been 35 cases in South Korea, making it the country with the most infections outside the Middle East where the disease was reported in 2012. There were 440 fatalities caused by the disease in the Middle East.

Recipients of suspected live anthrax samples may increase, says Department of Defense

The Department of Defense said that over the course of a one-year period, 51 labs in 17 states along with three different countries received samples of live anthrax. The department also said that this number may increase with further investigation.

According to Deputy Secretary of Defense Robert O. Work, the US Centers for Disease Control and Prevention (CDC) alerted the Pentagon on May 22 that the growth on live anthrax on a sample was detected by one of the private lab partners. CDC said that the live anthrax was ‘supposedly inactivated… we felt that it was [an] inactivate and safe shipment’. However, he added that it wasn’t like that.

Pages

News in Focus

Surfshark Discount Code – Get the Cheapest VPN Deal on the Market

If you’ve been thinking about boosting your online privacy without emptying your wallet, now is the perfect time to make the move.

PVR Inox Share Price Target at Rs 1,500: ICICI Securities

ICICI Securities has reiterated a BUY rating on PVR Inox with a robust 12-month target price of Rs1,500, reflecting a bullish stance on India’s multiplex leader.

Ethereum (ETH) Continues with Bullish Rally After a Brief Intraday Correction; Support Seen Around $4170

Ethereum (ETH) is experiencing a robust bullish surge in August 2025, underpinned by strong institutional participation, significant network enhancements, and a notable decline in Bitcoin dominance

SBK Sportsbook Strikes Multi-Year Deal with Huddersfield Town, Signaling a Bold Play in Sports Sponsorship

In a move reflecting the shifting strategies of modern sports sponsorships, SBK — the disruptive sportsbook app — has entered into a multi-year agreement to become the Official UK Betting Partner o

Ethereum Still Popular for Coin Launch Despite Low Fees at Solana, Cardano, TRON and Polygon

Ethereum continues to dominate as the preferred platform for launching new cryptocurrencies despite its relatively high transaction fees, a position primarily sustained by its mature ecosystem, rob

Harlequin Seeds Info 2025: Effects, Genetics & Benefits

Harlequin is a name that resonates deeply with anyone who has explored the therapeutic side of cannabis.